NCT07094893 2026-01-14
ARIEL-ENGIC
Gruppo Oncologico del Nord-Ovest
Phase 4 Not yet recruiting
Clinical Trials
14 trialsNCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT06090994 2025-05-07
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Fudan University
Phase 4 Recruiting
NCT06550453 2024-11-12
Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer
Xijing Hospital
Phase 4 Recruiting
NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
NCT06387368 2024-04-29
Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
Xi'an Jiaotong University
Phase 4 Not yet recruiting
NCT06217185 2024-02-28
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
Hebei Medical University Fourth Hospital
Phase 4 Recruiting
NCT04767828 2021-02-23
A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Unknown
NCT00812864 2018-08-28
capagec
University Hospital, Limoges
Phase 4 Completed
NCT03465202 2018-03-14
Association of Capecitabine Pharmacokinetics and Toxicity With Aging
Newcastle-upon-Tyne Hospitals NHS Trust
Phase 4 Unknown
NCT01641458 2016-02-02
FLOXTOX2
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT02380131 2015-03-05
Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
Hebei Medical University
Phase 4 Unknown
NCT01962376 2013-10-14
Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis
Hebei Medical University
Phase 4 Unknown
NCT00220168 2009-12-16
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Royal Marsden NHS Foundation Trust
Phase 4 Completed